Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 196

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

STINGel: Controlled release of a cyclic dinucleotide for enhanced cancer immunotherapy

Open access
Leach, David G., Dharmaraj, Neeraja, Piotrowski, Stacey L., Lopez-Silva, Tania L., Lei, Yu L., Sikora, Andrew G., Young, Simon, Hartgerink, Jeffrey D. · 2018 · Biomaterials

Abstract

Recent advancements in the field of immunotherapy have yielded encouraging results for the treatment of advanced cancers. Cyclic dinucleotides (CDNs) are a powerful new class of immunotherapy drugs known as STING (Stimulator of Interferon Genes) agonists, currently in clinical trials. However, previous studies of CDNs in murine cancer models have required multiple injections, and improve survival only in relatively nonaggressive tumor models. Therefore, we sought to improve the efficacy of CDN immunotherapy by developing a novel biomaterial we call “STINGel.” STINGel is an injectable peptide hydrogel that localizes and provides controlled release of CDN delivery, showing an 8-fold slower release rate compared to a standard collagen hydrogel. The carrier hydrogel is a positively charged, MultiDomain Peptide (MDP) which self-assembles to form a nanofibrous matrix and is easily delivered by syringe. The highly localized delivery of CDN from this nanostructured biomaterial affects the local histological response in a subcutaneous model, and dramatically improves overall survival in a challenging murine model of head and neck cancer compared to CDN alone or CDN delivered from a collagen hydrogel. This study demonstrates the feasibility of biomaterial-based immunotherapy platforms like STINGel as strategies for increasing the efficacy of CDN immunotherapies.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.biomaterials.2018.01.035

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 10 references

Cited by

See all 196

Metadata

Authors
Leach, D. G., Dharmaraj, N., Piotrowski, S. L., Lopez-Silva, T. L., Lei, Y. L., Sikora, A. G., Young, S., & Hartgerink, J. D.
Venue
Biomaterials
Publisher
Elsevier BV
Published
2018-05
Volume
163
Pages
67-75
ISSN
0142-9612 (ISSN-L)
OpenAlex
W2791182757
Cited by
196
References
10
FWCI
7.52
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: STINGel: Controlled release of a cyclic dinucleotide for enhanced cancer immunotherapy. https://app.cochat.ai/papers/10.1016/j.biomaterials.2018.01.035
The paper
Leach, D. G., Dharmaraj, N., Piotrowski, S. L., Lopez-Silva, T. L., Lei, Y. L., Sikora, A. G., Young, S., & Hartgerink, J. D. (2018). STINGel: Controlled release of a cyclic dinucleotide for enhanced cancer immunotherapy. Biomaterials. https://doi.org/10.1016/j.biomaterials.2018.01.035

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.